EKNL — EKO International Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for EKO International, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2000 June 30th | 2008 December 31st | 2009 December 31st | 2010 December 31st | 2011 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10KSB | ARS | ARS | ARS | ARS |
Standards: | USG | — | — | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 0.117 | 1.68 | 0 | 0 |
Cost of Revenue | |||||
Gross Profit | 0 | 0.008 | 1.2 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 0.699 | 1.13 | 1.89 | 0.519 | 0 |
Operating Profit | -0.699 | -1.01 | -0.211 | -0.519 | 0 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.8 | -1.01 | -0.367 | -0.519 | 0 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.801 | -1.01 | -0.367 | -0.519 | 0 |
Net Income Before Extraordinary Items | |||||
Net Income | -0.801 | -1.01 | -0.367 | -0.519 | 0 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | -0.801 | -1.01 | -0.367 | -0.519 | 0 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.194 | -0.003 | -0.002 | 0 | 0 |
Dividends per Share |